OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
Daniela Maria Tănase, Emilia Valasciuc, Evelina Maria Gosav, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8162-8162
Open Access | Times Cited: 24

Showing 24 citing articles:

Mechanistic insights from inflammasome structures
Jianing Fu, Kate Schroder, Hao Wu
Nature reviews. Immunology (2024) Vol. 24, Iss. 7, pp. 518-535
Closed Access | Times Cited: 60

Fatal attractions that trigger inflammation and drive atherosclerotic disease
Hitesh Sharma, Karen L. Mossman, Richard C. Austin
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 5
Open Access | Times Cited: 9

Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment
Ewa Radzioch, Bartłomiej Dąbek, Marta Balcerczyk-Lis, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 765-765
Open Access | Times Cited: 8

Shared pyroptosis pathways and crosstalk genes underpin inflammatory links between periodontitis and atherosclerosis
Pin-Xin Zhan, Zhiying Feng, Xinqi Huang, et al.
Immunobiology (2025) Vol. 230, Iss. 2, pp. 152880-152880
Open Access | Times Cited: 1

Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
Ye Tao, Weiyan Tao, Xiaoyi Chen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 1-13
Closed Access | Times Cited: 17

Legume-derived bioactive peptides: role in cardiovascular disease prevention and control
David Fonseca Hernandez, Luis Mojica, Elvira González de Mejı́a
Current Opinion in Food Science (2024) Vol. 56, pp. 101132-101132
Closed Access | Times Cited: 6

Modulation of atherosclerosis‐related signaling pathways by Chinese herbal extracts: Recent evidence and perspectives
Changxing Liu, Xinyi Guo, Xulong Zhang
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2892-2930
Closed Access | Times Cited: 5

Green Synthesis, Bio-evaluation, and In Silico Study of Dibenzalacetone: A Curcumin Analog for The Medicinal Treatment of Inflammatory Diseases
Aulia Abyyu, Reisa Astri Kusuma, A. Khairunnisa, et al.
Biocatalysis and Agricultural Biotechnology (2025), pp. 103561-103561
Closed Access

Harnessing Pyroptosis for Lung Cancer Therapy: The Impact of NLRP3 Inflammasome Activation
Rajiv Dahiya, Vijaykumar Sutariya, Sheeba Varghese Gupta, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155444-155444
Closed Access | Times Cited: 4

Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access

Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
Panagiotis Theofilis, Evangelos Oikonomou, Christos Chasikidis, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1211-1211
Open Access | Times Cited: 7

Therapeutic peptides for coronary artery diseases: in silico methods and current perspectives
Ayça Aslan, Selcen Arı Yuka
Amino Acids (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 2

An anti-inflammatory Glyburide-loaded nanoghost for atherosclerosis therapy: A red blood cell based bio-mimetic strategy
Zahra Karami, Mohammad Akrami, Jalil Mehrzad, et al.
Giant (2023) Vol. 16, pp. 100206-100206
Open Access | Times Cited: 6

Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease
Tianyu Wang, Juncan Ding, Xinyi Cheng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Design, synthesis and antitumor activity of 3,4,5-Trisubstituted Isoxazoles
Kanghui Duan, Fuxing Tan, Hongming Xie, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100203-100203
Open Access | Times Cited: 1

Molecular Links and Clinical Effects of Inflammation and Metabolic Background on Ischemic Stroke: An Update Review
Gaetano Pacinella, Anna Maria Ciaccio, Antonino Tuttolomondo
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7515-7515
Open Access | Times Cited: 1

MS4A6D Promotes carrageenan-induced footpad swelling in mice through enhancing macrophages-derived inflammation
Jing Guo, Chenhui Wang, Qun Xiang, et al.
Molecular Immunology (2024) Vol. 169, pp. 28-36
Closed Access

Secukinumab’ Cardioprotective Effect in Doxorubicin-induced cardiomyopathy: Targeting the NF-κB/NLRP3 Pathway in Rats
Mostafa D. Hassen, Nahla O. Mousa, Sara M. Radwan, et al.
Research Square (Research Square) (2024)
Open Access

Omics research in atherosclerosis
Kai-Jiang Tian, Yang Yu, G. Chen, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access

Використання інгібіторів дипептидилпептидази 4 д ля лікування атеросклерозу
Л.К. Соколова, V.M. Pushkarev, О.I. Kovzun, et al.
Endokrynologia (2024) Vol. 29, Iss. 2, pp. 172-182
Open Access

May the SSRIs play a role in the onset of peri- and post-menopausal cervical cancer?
Ciro Gargiulo Isacco, Raffaele Del Prete, Pietro Distratis, et al.
Deleted Journal (2024) Vol. 6, Iss. 7
Open Access

Page 1

Scroll to top